NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $44,000 | -75.6% | 106,242 | -69.9% | 0.00% | -81.8% |
| Q2 2017 | $180,000 | -36.6% | 353,400 | -28.5% | 0.01% | -38.9% |
| Q1 2017 | $284,000 | +6.4% | 494,000 | +17.6% | 0.02% | -18.2% |
| Q4 2016 | $267,000 | +24.2% | 420,000 | +78.2% | 0.02% | +29.4% |
| Q3 2016 | $215,000 | – | 235,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |